BioAdaptives, Inc.
BDPT
$0.0006
$0.000120.00%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -1,948.09% | 90.90% | 49.90% | -914.84% | 89.76% |
| Total Depreciation and Amortization | -128.72% | 5,271.43% | 0.00% | 0.00% | -84.44% |
| Total Amortization of Deferred Charges | 174.75% | -76.54% | 4.98% | -48.46% | -4.53% |
| Total Other Non-Cash Items | 267.94% | -379.55% | -83.56% | 345.03% | -180.40% |
| Change in Net Operating Assets | -176.92% | 7.06% | -12.37% | -9.35% | -41.85% |
| Cash from Operations | -62.75% | 1.41% | -191.79% | 29.09% | 55.28% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -181.66% | 139.67% | -- | -- | -8.74% |
| Total Debt Repaid | 100.00% | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | 84.73% | -- | -- | -8.74% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -181.52% | 227.49% | 275.38% | -430.51% | 123.69% |
